ELK3 and central nervous system cancer: The results revealed that the proliferation and migration ability of U251 cells decreased after the expression of ELK3. As IDH mutation was firstly discovered in diffuse gliomas in 2009, the treatment in diffuse gliomas has gained an increasing prominent role due to its key significance in the diagnosis, prognosis, and prediction of gliomas (27–29).